These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 11964851)

  • 21. [Current news about epidemiology of syncytial respiratory virus infection].
    Palumbo E
    Recenti Prog Med; 2008 May; 99(5):237-9. PubMed ID: 18581965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bronchiolitis.
    Lozano JM
    Clin Evid; 2002 Dec; (8):291-303. PubMed ID: 12603884
    [No Abstract]   [Full Text] [Related]  

  • 23. Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection-related morbidity.
    Broughton S; Greenough A
    Expert Opin Pharmacother; 2003 Oct; 4(10):1801-8. PubMed ID: 14521489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing RSV bronchiolitis in vulnerable infants: the role of palivizumab.
    Fitzgerald DA
    Paediatr Respir Rev; 2009 Sep; 10(3):143-7. PubMed ID: 19651385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.
    Piedimonte G; King KA; Holmgren NL; Bertrand PJ; Rodriguez MM; Hirsch RL
    Pediatr Res; 2000 Mar; 47(3):351-6. PubMed ID: 10709734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bronchiolitis.
    Lozano JM; Wang E
    Clin Evid; 2002 Jun; (7):272-82. PubMed ID: 12230650
    [No Abstract]   [Full Text] [Related]  

  • 27. [Palivizumab and bronchiolitis: need to apply the efficiency in order to join clinical practice to scientific studies].
    González de Dios J; Ochoa Sangrador C
    Med Clin (Barc); 2005 Apr; 124(12):478-9. PubMed ID: 15826590
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of corticosteroids for treatment of respiratory syncytial virus bronchiolitis and pneumonia in cotton rats.
    Ottolini MG; Curtis SJ; Porter DD; Mathews A; Richardson JY; Hemming VG; Prince GA
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2299-302. PubMed ID: 12069994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guidelines for respiratory syncytial virus prophylaxis. An update].
    Carbonell-Estrany X; Quero Jiménez J
    An Esp Pediatr; 2002 Apr; 56(4):334-6. PubMed ID: 11927077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential impact of prophylaxis against bronchiolitis due to the respiratory syncytial virus in children with congenital cardiac malformations.
    Rackham OJ; Thorburn K; Kerr SJ
    Cardiol Young; 2005 Jun; 15(3):251-5. PubMed ID: 15865826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory syncytial virus (RSV) immune globulin and palivizumab for prevention of RSV infection.
    Robinson RF; Nahata MC
    Am J Health Syst Pharm; 2000 Feb; 57(3):259-64. PubMed ID: 10674778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory syncytial virus: how, why and what to do.
    Rodriguez R; Ramilo O
    J Infect; 2014 Jan; 68 Suppl 1():S115-8. PubMed ID: 24171820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus (RSV) as a common cause of respiratory illness in children younger than 5 years.
    Poehling KA; Hickson GB
    Ambul Pediatr; 2003; 3(6):342-4. PubMed ID: 14616052
    [No Abstract]   [Full Text] [Related]  

  • 34. Respiratory syncytial virus therapy and prophylaxis: have we finally turned the corner?
    Hegele RG
    Eur Respir J; 2011 Aug; 38(2):246-7. PubMed ID: 21804160
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological management of human respiratory syncytial virus infection.
    Kalergis AM; Soto JA; Gálvez NMS; Andrade CA; Fernandez A; Bohmwald K; Bueno SM
    Expert Opin Pharmacother; 2020 Dec; 21(18):2293-2303. PubMed ID: 32808830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Respiratory syncytial virus].
    Seidenberg J
    Internist (Berl); 2019 Nov; 60(11):1146-1150. PubMed ID: 31486858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory syncytial virus: different criteria for palivizumab use in different areas?
    Mitchell I
    South Med J; 2007 Jul; 100(7):661-2. PubMed ID: 17639741
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey.
    Prais D; Danino D; Schonfeld T; Amir J
    Chest; 2005 Oct; 128(4):2765-71. PubMed ID: 16236953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of respiratory syncytial virus with lower respiratory tract infection in infants and children.
    Garzon LS; Wiles L
    AACN Clin Issues; 2002 Aug; 13(3):421-30. PubMed ID: 12151995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.